Table 3.
DH Gene Utilization in Transfected BOSC23 Cells, Pre-B Cells, and Peripheral Blood
| BOSC23 transfected with RAG1/2 and: | |||||
|---|---|---|---|---|---|
| Family | Genes | E2A | EBF | Pre-B | PBLs |
| DH3 | 3-3 (DXP4) | 2 (11%) | 4 (22%) | 4 (25%) | 42 (24%) |
| 3-9 (DXP1) | 5 (28%) | 2 (13%) | 19 (11%) | ||
| 3-10 (DXP′1) | 1 (8%) | 2 (11%) | 1 (6%) | 73 (41%) | |
| 3-16 (D21/10) | 1 (8%) | 3 (19%) | 9 (5%) | ||
| 3-22 (D21/9) | 15 (79%) | 7 (39%) | 6 (38%) | 34 (19%) | |
| DH3 | 4-4 (DA4) | 2 (4%) | 10 (32%) | 3 (8%) | |
| 4-11 (DA1) | 2 (6%) | 3 (8%) | |||
| 4-17 | 2 (4%) | 5 (16%) | 4 (27%) | 21 (57%) | |
| 4-23 | 44 (91%) | 14 (45%) | 11 (73%) | 10 (27%) | |